SETD1A is involved in cell proliferation in various cancers, including lung cancer, colorectal cancer, hepatocellular carcinoma, and leukemia, and in the development of resistance to anticancer drugs 60-67. This evidence concerns the gene SETD1A and colorectal cancer.